Placeholder while article actions loadExpert advisers to the Food and Drug Administration meet Wednesday to review scientific evidence on coronavirus vaccines for the nation’s young children, the last group in the United States not yet eligible for shots. The Moderna vaccine would be for children 6 months through 5 years old, and the Pfizer-BioNTech vaccine for children 6 months through 4 years old. The FDA could act on the recommendation within days, potentially setting the stage for shots to be available next week to at least 19 million infants, toddler and young children. The Centers for Disease Control and Prevention plans to convene a panel of external advisers Friday and Saturday to review the shots for young children. Some larger pediatric practices have preordered both Moderna and Pfizer-BioNTech vaccines.

Source: Washington Post June 15, 2022 02:27 UTC